<p>Genmab A/S has announced a partnership with Anthropic to enhance its research and development processes using advanced artificial intelligence capabilities. Through this collaboration, Genmab and Anthropic will design and implement custom, Claude-powered agentic AI solutions to support Genmab’s clinical development priorities. The integration of AI is expected to accelerate data processing, analysis, and document generation within defined guardrails and under human oversight, streamlining operational activities and improving consistency as Genmab advances its clinical programs toward key regulatory milestones. This initiative aligns with Genmab’s strategy to create a more scalable, efficient, and digitally enabled R&amp;D engine. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genmab A/S published the original content used to generate this news brief via Business Wire (Ref. ID: 20260107361677) on January 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

Genmab Partners with Anthropic to Boost R&D with AI Solutions